Please login to the form below

Not currently logged in
Email:
Password:

Roche's Chugai recalls Vesanoid in Japan

Roche's Japanese subsidiary Chugai has recalled its Vesanoid capsules for acute promyelocytic leukemia in Japan.

Roche's Japanese subsidiary Chugai has recalled its Vesanoid capsules for acute promyelocytic leukemia in Japan.

The recall follows the discovery of bovine-derived material sourced from Canada in a specific batch of the capsules imported from Roche, which is based in Switzerland.

Use of such material requires a partial amendment to the approval document for use in Japan.

Chugai and Roche had agreed not to export Vesanoid capsules using the material to Japan, but went ahead with the exportation anyway because Roche believed that its use was approved in the region.

Vesanoid had annual sales of approximately USD 24m for the twelve months ended April 2007, based on IMS sales data.

3rd August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....